Cell Systems’ primary human glomerular microvascular endothelial cells (ACBRI 128) and glomerular mesangial cells (ACBRI 127) are optimized for glomerular barrier models, renal endothelial cell culture, and kidney-on-chip research.
These early passage, antibody-free cells are validated in peer-reviewed studies for expression of key markers such as CD31, CD105, Annexin V, ICAM1, and GLP-1R. Applications include glomerular endothelial cell culture, apoptosis assays, transendothelial signaling studies, and integration into glomerulus chip systems.
With demonstrated performance in inflammation, cell–cell signaling, gene expression, and barrier integrity assays, these human glomerular endothelial cells and mesangial cells are ideal for 2D/3D glomerular cell culture, renal disease modeling, and microvascular chip development.
Key Features:
- Early passage cells, Passage 3 (<12 population doublings)
- Antibody-free isolation
- High viability (~85%), 1M cells per vial
- Supports 2D/3D culture, organ-on-chip, and co-culture
- Shipped as frozen vials or proliferating flasks
- Consistency across long-term studies with deep inventory from a single donor lot.
